Tilray Stands Out with its Global Supply Agreements


August 8, 2018: Tilray Inc. (NASDAQ:TLRY) is focused on the research, cultivation, production and distribution of medical cannabis and cannabinoids. The Company is the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified, as per European Medicine Agency (EMA) standards. Currently, Tilray serves several physicians, pharmacies, governments, hospitals, and researchers across continents via its affiliated entities in Australia and New Zealand (Tilray Australia New Zealand Pty Ltd), Canada (Tilray Canada Ltd), Germany (Tilray Deutschland GmbH), and Portugal (Tilray Portugal Unipessoal Lda). Watch: Cannex Capital Holdings (CSE:CNNX) Wants to Emerge as a Multi-State U.S. Tilray Stands Out with its Global Supply Agreements

thumbnail courtesy of smallcappower.com


Please enter your comment!
Please enter your name here